Dendreon Corp.
Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington…
Exelixis, Inc.
Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and …
Favrille, Inc.
Biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system…
Heal Corporation
Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities…
ImmunoGen, Inc.
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Ca…
OSI Pharmaceuticals Inc.
Researches and develops diagnostics and anticancer therapy in humans and other diseases associated with control of cell growth. Laboratories in Oxford, Boulder and Farmingdale, hea…
Panacea Pharmaceuticals, Inc.
Focused on utilizing functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases with substantial unmet clinical need.
Serenex, Inc.
Drug discovery and development through the commercialization of chemoproteomics, fractionation and mining, purine-binding, mechanism of action determination, and toxicity screening…
Showing 20–8 of 8 results